Zynex Faces Securities Fraud Lawsuit
Analysis based on 14 articles · First reported Mar 02, 2026 · Last updated Mar 11, 2026
The market is negatively impacted by the news of a class action lawsuit against Zynex, leading to a potential decline in its stock price and investor confidence. This event also highlights the risks associated with companies engaging in aggressive sales strategies over compliance.
Zynex, Inc. is facing a class action securities lawsuit filed by Levi & Korsinsky, LLP on behalf of investors who suffered losses between February 25, 2021, and December 15, 2025. The lawsuit alleges that Zynex engaged in a fraudulent overbilling scheme, shipping products in excess of need to inflate revenue. This practice drew scrutiny from insurers, including United States===Tricare. The Travelers Companies had previously commenced an action against Zynex and its executives, seeking over $23 million in damages for fraudulent claims. The complaint further alleges that Zynex's management prioritized aggressive sales over compliance, leading to inflated order growth and a lack of strong internal controls. Defendants' positive statements about the company's business were allegedly misleading, and Zynex is likely to face adverse consequences, including removal from insurer networks and government penalties.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard